tm
Seeing Is Believing
tm
Seeing Is Believing
Currently out of the existing stock ratings of Steve Beuchaw, 20 are a SELL (22.99%), 36 are a HOLD (41.38%), 31 are a BUY (35.63%).
Analyst Steve Beuchaw, currently employed carries an average stock price target met ratio of 76.22% that have a potential upside of 18.26% achieved within 270 days. Previously, Steve Beuchaw worked at WOLFE.
Steve Beuchaw’s has documented 174 price targets and ratings displayed on 18 stocks. The coverage was on the Healthcare sector.
Most recent stock forecast was given on QGEN, Qiagen NV at 16-Feb-2024.
Analyst best performing recommendations are on ALGN (ALIGN TECHNOLOGY).
The best stock recommendation documented was for ALGN (ALIGN TECHNOLOGY) at 10/9/2018. The price target of $320 was fulfilled within 1 day with a profit of $20.97 (6.15%) receiving and performance score of 61.5.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Sell
$206
$-5.06 (-2.40%)
$180
8 days ago
(13-Dec-2024)
6/8 (75%)
$-29.44 (-12.50%)
309
Buy
$275
$63.94 (30.29%)
$285
1 months 27 days ago
(24-Oct-2024)
27/38 (71.05%)
$58.58 (27.07%)
149
Buy
$250
$38.94 (18.45%)
$270
1 months 27 days ago
(24-Oct-2024)
5/11 (45.45%)
$33.58 (15.52%)
273
Buy
$275
$63.94 (30.29%)
$285
1 months 27 days ago
(24-Oct-2024)
14/33 (42.42%)
$58.58 (27.07%)
93
Buy
$276
$64.94 (30.77%)
$325
1 months 27 days ago
(24-Oct-2024)
21/29 (72.41%)
$59.58 (27.53%)
97
What Year was the first public recommendation made by Steve Beuchaw?
